Drug Induced Thrombotic Microangiopathy with Certolizumab Pegol
Background:Certolizumab pegol is used to treat ankylosing spondylitis, Crohn’s disease, psoriatic arthritis, and rheumatoid arthritis. Unlike other monoclonal antibodies such as infliximab and adalimumab, certolizumab does not contain an Fc fraction and hence does not induce complement activation. I...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Trakya University
2018-09-01
|
| シリーズ: | Balkan Medical Journal |
| 主題: | |
| オンライン･アクセス: |
http://balkanmedicaljournal.org/archives/archive-detail/article-preview/drug-nduced-thrombotic-microangiopathy-with-certol/19696
|
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|